<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Gupta A</submitter><funding>Ministry of Education - Singapore</funding><pagination>404</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12487525</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>23(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Advancements in chemotherapy have improved outcomes for rhabdomyosarcoma (RMS), the most common soft tissue sarcoma in children. However, relapse-free survival rates remain below 20% in metastatic alveolar rhabdomyosarcoma (ARMS). Tumor-initiating cells (TICs) drive recurrence. Targeting this pool of cells has been shown to reduce relapse rates and metastasis in various cancers. Emerging evidence implicates lipid metabolism in supporting stem-like properties in cancer. However, TICs remain poorly characterized in ARMS. This study investigates the transcriptomic and metabolic profile of TICs in ARMS.&lt;h4>Methods&lt;/h4>Transcriptomic and lipidomic profiling were performed on tumorsphere-derived and adherent cells from ARMS cells. Differential expression of metabolic genes and</pubmed_abstract><journal>Cell communication and signaling : CCS</journal><pubmed_title>PLA2 driven lipid signaling drives ARMS tumorigenic cell properties.</pubmed_title><pmcid>PMC12487525</pmcid><funding_grant_id>MOE-T2EP30222-0014</funding_grant_id><pubmed_authors>Ramanathan B</pubmed_authors><pubmed_authors>Gupta A</pubmed_authors><pubmed_authors>Loh AHP</pubmed_authors><pubmed_authors>Das D</pubmed_authors><pubmed_authors>Taneja R</pubmed_authors><pubmed_authors>Vadivellu A</pubmed_authors></additional><is_claimable>false</is_claimable><name>PLA2 driven lipid signaling drives ARMS tumorigenic cell properties.</name><description>&lt;h4>Background&lt;/h4>Advancements in chemotherapy have improved outcomes for rhabdomyosarcoma (RMS), the most common soft tissue sarcoma in children. However, relapse-free survival rates remain below 20% in metastatic alveolar rhabdomyosarcoma (ARMS). Tumor-initiating cells (TICs) drive recurrence. Targeting this pool of cells has been shown to reduce relapse rates and metastasis in various cancers. Emerging evidence implicates lipid metabolism in supporting stem-like properties in cancer. However, TICs remain poorly characterized in ARMS. This study investigates the transcriptomic and metabolic profile of TICs in ARMS.&lt;h4>Methods&lt;/h4>Transcriptomic and lipidomic profiling were performed on tumorsphere-derived and adherent cells from ARMS cells. Differential expression of metabolic genes and</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Oct</publication><modification>2026-06-04T04:21:09.783Z</modification><creation>2026-05-04T03:14:17.725Z</creation></dates><accession>S-EPMC12487525</accession><cross_references><pubmed>41034946</pubmed><doi>10.1186/s12964-025-02409-3</doi></cross_references></HashMap>